21 U.S.C. § 1536 — Community-based coalition enhancement grants to address local drug crises

submitted 10 years ago by Pub. L. 114-198 to r/title-21-FOOD-AND-DRUGS · 779 words · no verdicts yet

in plain englishAI-generated · not legal advice

The Office of National Drug Control Policy can give grants to fight local opioid and methamphetamine crises. Eligible groups must already run Drug-Free Communities Act programs in high-abuse areas. Congress authorized $5,000,000 a year for these grants from 2017 through 2021.

This section lets the federal government give grants to local groups fighting opioid and methamphetamine crises. (a) Definitions. The "Administrator" runs the Substance Abuse and Mental Health Services Administration. The "Director" runs the Office of National Drug Control Policy. An "eligible entity" already holds a Drug-Free Communities Act grant. It also shows local data proving high opioid or methamphetamine abuse. A "local drug crisis" means a sudden spike in such abuse. It can also mean sustained high abuse, or a sudden rise in opioid deaths. An "emerging drug abuse issue" means a sudden jump in treatment demand paired with insufficient local resources. An "opioid" is a drug with addiction risks like morphine. (b) The Director works with the Administrator. Together they may grant funds to eligible entities for community-wide strategies against these crises. (c) An eligible entity applies as the Director requires. It must submit a detailed, multisector plan for its area's crisis. (d) Grant money must fund the approved prevention plan. It also funds related training, technical assistance, and programs addressing emerging drug issues. (e) Grantees must use federal funds to add to existing funding. They may never use it to replace other funding sources. (f) Grants face the same evaluation rules as Drug-Free Communities Act grants. They may also be judged on reducing abuse. (g) No more than 8 percent of a year's funds may pay for administrative expenses. (h) The Director may delegate grant-related authority to the Administrator. This happens through an interagency agreement. (i) Congress authorized $5,000,000 for each fiscal year from 2017 through 2021.

facts

- Codified at 21 U.S.C. § 1536, titled "Community-based coalition enhancement grants to address local drug crises." - Enacted by Pub. L. 114–198, title I, § 103, on July 22, 2016 (130 Stat. 699). - Contains a single source-credit reference, with an amendment count of 1. - The provision comprises 779 words across nine subsections (a)–(i). - Authorizes appropriations of $5,000,000 annually for fiscal years 2017 through 2021.

the actual law source: uscode.house.gov ↗public domain

(a) Definitions

In this section:

(1) Administrator

The term “Administrator” means the Administrator of the Substance Abuse and Mental Health Services Administration.

(2) Director

The term “Director” means the Director of the Office of National Drug Control Policy.

(3) Drug-Free Communities Act of 1997

The term “Drug-Free Communities Act of 1997” means chapter 2 of the National Narcotics Leadership Act of 1988 (21 U.S.C. 1521 et seq.).

(4) Eligible entity

The term “eligible entity” means an organization that—

(A)

on or before the date of submitting an application for a grant under this section, receives or has received a grant under the Drug-Free Communities Act of 1997; and

(B)

has documented, using local data, rates of abuse of opioids or methamphetamines at levels that are—

(i)

significantly higher than the national average as determined by the Secretary (including appropriate consideration of the results of the Monitoring the Future Survey published by the National Institute on Drug Abuse and the National Survey on Drug Use and Health published by the Substance Abuse and Mental Health Services Administration); or

(ii)

higher than the national average, as determined by the Secretary (including appropriate consideration of the results of the surveys described in clause (i)), over a sustained period of time.

(5) Emerging drug abuse issue

The term “emerging drug abuse issue” means a substance use disorder within an area involving—

(A)

a sudden increase in demand for particular drug abuse treatment services relative to previous demand; and

(B)

a lack of resources in the area to address the emerging problem.

(6) Local drug crisis

The term “local drug crisis” means, with respect to the area served by an eligible entity—

(A)

a sudden increase in the abuse of opioids or methamphetamines, as documented by local data;

(B)

the abuse of prescription medications, specifically opioids or methamphetamines, that is significantly higher than the national average, over a sustained period of time, as documented by local data; or

(C)

a sudden increase in opioid-related deaths, as documented by local data.

(7) Opioid

The term “opioid” means any drug having an addiction-forming or addiction-sustaining liability similar to morphine or being capable of conversion into a drug having such addiction-forming or addiction-sustaining liability.

(b) Program authorized

The Director, in coordination with the Administrator, may make grants to eligible entities to implement comprehensive community-wide strategies that address local drug crises and emerging drug abuse issues within the area served by the eligible entity.

(1) In general

An eligible entity seeking a grant under this section shall submit an application to the Director at such time, in such manner, and accompanied by such information as the Director may require.

(2) Criteria

As part of an application for a grant under this section, the Director shall require an eligible entity to submit a detailed, comprehensive, multisector plan for addressing the local drug crisis or emerging drug abuse issue within the area served by the eligible entity.

(d) Use of funds

An eligible entity shall use a grant received under this section—

(1)

for programs designed to implement comprehensive community-wide prevention strategies to address the local drug crisis in the area served by the eligible entity, in accordance with the plan submitted under subsection (c)(2);

(2)

to obtain specialized training and technical assistance from the organization funded under section 4 of Public Law 107–82 (21 U.S.C. 1521 note); and

(3)

for programs designed to implement comprehensive community-wide strategies to address emerging drug abuse issues in the community.

(e) Supplement not supplant

An eligible entity shall use Federal funds received under this section only to supplement the funds that would, in the absence of those Federal funds, be made available from other Federal and non-Federal sources for the activities described in this section, and not to supplant those funds.

(f) Evaluation

A grant under this section shall be subject to the same evaluation requirements and procedures as the evaluation requirements and procedures imposed on the recipient of a grant under the Drug-Free Communities Act of 1997, and may also include an evaluation of the effectiveness at reducing abuse of opioids or methamphetamines.

(g) Limitation on administrative expenses

Not more than 8 percent of the amounts made available to carry out this section for a fiscal year may be used to pay for administrative expenses.

(h) Delegation authority

The Director may enter into an interagency agreement with the Administrator to delegate authority for the execution of grants and for such other activities as may be necessary to carry out this section.

(i) Authorization of appropriations

For the purpose of carrying out this section, there are authorized to be appropriated $5,000,000 for each of fiscal years 2017 through 2021.

Source credit: (Pub. L. 114–198, title I, § 103, July 22, 2016, 130 Stat. 699.)

history & why it existsrecord from the source credit

2016Enacted · Pub. L. 114-198 · 130 Stat. 699

The record. According to the source credit, this section was enacted as part of Public Law 114–198, title I, § 103, approved July 22, 2016, and published at 130 Stat. 699. The source credit does not reflect any subsequent amendment to the text since its original enactment. Historical context. Public Law 114–198 is the Comprehensive Addiction and Recovery Act of 2016 (CARA), legislation generally understood to have been enacted in response to the escalating opioid and methamphetamine crisis that drew significant national attention during that period. CARA is commonly described as a broad federal effort to expand prevention, treatment, recovery, and law-enforcement resources directed at substance use disorders, particularly opioid misuse. Within that broader framework, this section's placement alongside references to the Drug-Free Communities Act of 1997 suggests it was designed to build upon that earlier program by authorizing supplemental grants to community coalitions already engaged in drug-prevention work, targeting localities experiencing acute or sustained drug crises. This connection is consistent with the general understanding of CARA's purpose, but the record here does not itself document the specific legislative reasoning, deliberations, or findings that led Congress to adopt this particular grant mechanism, its eligibility criteria, or its funding structure. Beyond the general historical context of the opioid crisis and CARA's broadly stated aims, the materials provided do not establish the precise intent behind this section's specific provisions.

all 0 arguments · sorted by: best

no arguments yet — make the first case